These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33578261)

  • 21. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
    Garabadu D; Agrawal N
    Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine, a key factor of mitochondrial damage and neuronal toxicity on rotenone exposure and also parkinsonic motor dysfunction-Impact of asiaticoside with a probable vesicular involvement.
    Margabandhu G; Vanisree AJ
    J Chem Neuroanat; 2020 Jul; 106():101788. PubMed ID: 32278634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
    Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA
    Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
    Abdelsalam RM; Safar MM
    J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study.
    Zhang ZN; Zhang JS; Xiang J; Yu ZH; Zhang W; Cai M; Li XT; Wu T; Li WW; Cai DF
    Brain Res; 2017 Jan; 1655():104-113. PubMed ID: 27876560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain.
    Kelly R; Bemelmans AP; Joséphine C; Brouillet E; McKernan DP; Dowd E
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
    Moradi Vastegani S; Khoshnam SE; Ghafouri S; Bakhtiari N; Farbood Y; Sarkaki A
    PLoS One; 2023; 18(11):e0294612. PubMed ID: 37972114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson's disease model.
    Sayed AS; El Sayed NS; Budzyńska B; Skalicka-Woźniak K; Ahmed MK; Kandil EA
    Life Sci; 2022 Dec; 310():121129. PubMed ID: 36306871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caffeine alleviates anxiety-like behavior and brainstem lesions in a rotenone-induced rat model of Parkinson's disease.
    Adeyeye TA; Babatunde BR; Ehireme SE; Shallie PD
    J Chem Neuroanat; 2023 Oct; 132():102315. PubMed ID: 37481171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Phenyl valeric acid attenuates α-synuclein aggregation and endoplasmic reticulum stress in rotenone-induced Parkinson's disease rats: A molecular mechanistic study.
    Kaur N; Singh R; Dhingra N; Kaur T
    Biochem Pharmacol; 2024 Aug; 226():116343. PubMed ID: 38852645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of evening primrose oil on behavioral activities, nigral microglia and histopathological changes in a rat model of rotenone-induced parkinsonism.
    Mohammad HMF; El-Baz AA; Mahmoud OM; Khalil S; Atta R; Imbaby S
    J Chem Neuroanat; 2023 Jan; 127():102206. PubMed ID: 36464068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
    Kandil EA; Abdelkader NF; El-Sayeh BM; Saleh S
    Neuroscience; 2016 Sep; 332():26-37. PubMed ID: 27365173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
    Lin CH; Huang JY; Ching CH; Chuang JI
    J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V; Cannon JR; Greenamyre JT
    J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
    Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
    Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease).
    El-Horany HE; El-Latif RN; ElBatsh MM; Emam MN
    J Biochem Mol Toxicol; 2016 Jul; 30(7):360-9. PubMed ID: 27252111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model.
    Zahra W; Rai SN; Birla H; Singh SS; Rathore AS; Dilnashin H; Singh R; Keswani C; Singh RK; Singh SP
    CNS Neurol Disord Drug Targets; 2020; 19(7):527-540. PubMed ID: 32787765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D₁ and D₂ receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: effect of serotonin, dopamine and norepinephrine.
    Paul J; Nandhu MS; Kuruvilla KP; Paulose CS
    Neurol Res; 2010 Nov; 32(9):918-24. PubMed ID: 20887679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of caloric vestibular stimulation in improvement of motor symptoms and inhibition of neuronal degeneration in rotenone model of Parkinson's disease - An experimental study.
    Thanalakshmi J; Archana R; Senthilkumar S; Shakila R; Pazhanivel N; Subhashini S
    Physiol Int; 2020 Oct; 107(3):390-405. PubMed ID: 33021954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.